Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Chinese Pharma Rallies, Singapore Stocks Rise, Samsung Climbs | Stock Movers
Posted
August 11, 2026
Views
338
Likes
2
Engagement
0.59%
August 11, 2026
338
2
0.59%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
4:40Now PlayingToday's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Gan & Lee Pharmaceuticals shares rise alongside other Chinese weight loss-related stocks after the company signed an exclusive licensing deal with A. Menarini International to commercialize its obesity drug across 39 European markets.
- Yangzijiang Shipbuilding shares rise alongside other Singapore stocks as the city state upgraded its 2026 economic growth forecast.
- Samsung shares climb as much as 5.7% on expectations of a massive shareholder return package, which follow a boost in sentiment after the release of strong 10-day exports data.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Chinese Pharma Rallies, Singapore Stocks Rise, Samsung Climbs
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
